Respiratory involvement in antineutrophil cytoplasmic antibody-associated vasculitides: a retrospective study based on POLVAS registry.


Journal

Clinical and experimental rheumatology
ISSN: 0392-856X
Titre abrégé: Clin Exp Rheumatol
Pays: Italy
ID NLM: 8308521

Informations de publication

Date de publication:
May 2022
Historique:
received: 06 04 2021
accepted: 30 08 2021
pubmed: 30 4 2022
medline: 11 5 2022
entrez: 29 4 2022
Statut: ppublish

Résumé

The study aimed to characterise the Polish population of (ANCA)-associated vasculitides (AAV) with respiratory involvement (RI), in comparison to the subgroup without lung manifestations and the other cohorts. Retrospective analysis of the Polish population of AAV with RI was conducted, based on data from the POLVAS registry. Standard descriptive statistics, χ2 test, and Mann-Whitney U test were used to perform comparisons. Among 461 cases qualified to this study, there were 316 cases with RI (68.5%), 206 with granulomatosis with polyangiitis (GPA) (65.2%), 80 with eosinophilic granulomatosis with polyangiitis (EGPA) (25.3%) and 30 with microscopic polyangiitis (MPA) (9.5%). Proportion of RI in GPA, MPA, and EGPA accounted for 67.8%; 40.0%; 97.6%, respectively. The number of relapses was higher in the RI group (median 1.0 vs. 0.0; p=0.01). In the subgroup of combined GPA and MPA with RI, the trends toward higher proportion of deaths (11.7% vs. 5.7%; p=0.07), relapses requiring hospitalisation (52.2% vs. 42.4%, p=0.07) and relapses requiring admission to the intensive care unit (5.6% vs. 1.4%, p=0.09) were observed, median maximal concentration of CRP was higher (46 vs. 25 mg/l; p=0.01) and more aggressive treatment was administered. Prevalence of RI in the Polish population of AAV is similar to the values reported in the literature, however, the proportion observed in GPA is closer to those presented in Asian than Western European cohorts. RI seems to be associated with a more severe course of disease and its presence prompts more aggressive treatment.

Identifiants

pubmed: 35485410
pii: 17297
doi: 10.55563/clinexprheumatol/tvtyen
doi:

Substances chimiques

Antibodies, Antineutrophil Cytoplasmic 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

720-726

Auteurs

Grzegorz Biedroń (G)

2nd Department of Internal Medicine, Jagiellonian University Medical College, Kraków, Poland.

Anna Włudarczyk (A)

Centre for Intensive Care and Perioperative Medicine, Jagiellonian University Medical College, Kraków, Poland.

Katarzyna Wawrzycka-Adamczyk (K)

2nd Department of Internal Medicine, Jagiellonian University Medical College, Kraków, Poland.

Krzysztof Wójcik (K)

2nd Department of Internal Medicine, Jagiellonian University Medical College, Kraków, Poland.

Jacek Musiał (J)

2nd Department of Internal Medicine, Jagiellonian University Medical College, Kraków, Poland.

Stanisława Bazan-Socha (S)

2nd Department of Internal Medicine, Jagiellonian University Medical College, Kraków, Poland.

Zbigniew Zdrojewski (Z)

Department of Internal Medicine, Connective Tissue Diseases and Geriatrics, Medical University of Gdańsk, Poland.

Anna Masiak (A)

Department of Internal Medicine, Connective Tissue Diseases and Geriatrics, Medical University of Gdańsk, Poland.

Zenobia Czuszyńska (Z)

Department of Internal Medicine, Connective Tissue Diseases and Geriatrics, Medical University of Gdańsk, Poland.

Maria Majdan (M)

Department of Rheumatology and Connective Tissue Diseases, Medical University of Lublin, Poland.

Radosław Jeleniewicz (R)

Department of Rheumatology and Connective Tissue Diseases, Medical University of Lublin, Poland.

Marian Klinger (M)

Department of Nephrology and Transplantation Medicine, Wroclaw Medical University, Wrocław, and Department of Nephrology and Internal Medicine, University of Opole, Poland.

Magdalena Krajewska (M)

Department of Nephrology and Transplantation Medicine, Wroclaw Medical University, Wrocław, Poland.

Hanna Augustyniak-Bartosik (H)

Department of Nephrology and Transplantation Medicine, Wroclaw Medical University, Wrocław, Poland.

Katarzyna Jakuszko (K)

Department of Nephrology and Transplantation Medicine, Wroclaw Medical University, Wrocław, Poland.

Marek Brzosko (M)

Department of Rheumatology and Internal Diseases, Pomeranian Medical University in Szczecin, Poland.

Iwona Brzosko (I)

Department of Rheumatology and Internal Diseases, Pomeranian Medical University in Szczecin, Poland.

Alicja Dębska-Ślizień (A)

Department of Nephrology, Transplantology and Internal Diseases, Medical University of Gdańsk, Poland.

Hanna Storoniak (H)

Department of Nephrology, Transplantology and Internal Diseases, Medical University of Gdańsk, Poland.

Barbara Bułło-Piontecka (B)

Department of Nephrology, Transplantology and Internal Diseases, Medical University of Gdańsk, Poland.

Witold Tłustochowicz (W)

Department of Internal Medicine and Rheumatology, Military Institute of Medicine, Warszawa, Poland.

Joanna Kur-Zalewska (J)

Department of Internal Medicine and Rheumatology, Military Institute of Medicine, Warszawa, and Clinical Research Support Centre, Military Institute of Medicine, Warszawa, Poland.

Małgorzata Wisłowska (M)

Department of Internal Diseases and Rheumatology, Central Clinical Hospital of the Ministry of the Interior and Administration, Warszawa, Poland.

Marta Madej (M)

Department of Rheumatology and Internal Medicine, Wroclaw Medical University, Wrocław, Poland.

Anna Hawrot-Kawecka (A)

Department of Internal Medicine and Metabolic Diseases, Medical University of Silesia, Katowice, Poland.

Piotr Głuszko (P)

Department of Rheumatology, National Institute of Geriatrics, Rheumatology and Rehabilitation, Warszawa, Poland.

Eugeniusz J Kucharz (EJ)

Department of Internal Medicine, Rheumatology and Clinical Immunology, Medical University of Silesia, Katowice, Poland.

Wojciech Szczeklik (W)

Centre for Intensive Care and Perioperative Medicine, Jagiellonian University Medical College, Kraków, Poland. wojciech.szczeklik@uj.edu.pl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH